Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDVL

MedAvail (MDVL) Stock Price, News & Analysis

MedAvail logo

About MedAvail Stock (NASDAQ:MDVL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.80
$5.95
52-Week Range
N/A
Volume
245,100 shs
Average Volume
261,432 shs
Market Capitalization
$2.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

MDVL Stock News Headlines

Delhi Bank Corp DWNX
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

MDVL Stock Analysis - Frequently Asked Questions

MedAvail Holdings, Inc. (NASDAQ:MDVL) issued its quarterly earnings data on Monday, November, 8th. The company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by $0.02. The company earned $5.79 million during the quarter. MedAvail had a negative net margin of 192.97% and a negative trailing twelve-month return on equity of 218.10%.

Based on aggregate information from My MarketBeat watchlists, some other companies that MedAvail investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Braze (BRZE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/08/2021
Today
6/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Current Symbol
NASDAQ:MDVL
Employees
279
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.62 million
Net Margins
-192.97%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$43.33 million
Price / Cash Flow
N/A
Book Value
$13.01 per share
Price / Book
N/A

Miscellaneous

Free Float
1,590,000
Market Cap
$2.91 million
Optionable
No Data
Beta
0.76
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:MDVL) was last updated on 6/19/2025 by MarketBeat.com Staff
From Our Partners